Showing results (461-470 of 980) with videos related to
Sort By:
Pageof 98
Current Drug Safety|February 16, 2019
Idiosyncratic Drug-Induced Acute Liver Failure: A Challenging and Distressing ScenarioCarla Stefania Colaci, Manuel Mendizabal, Fernando BessoneCurrent Drug Safety|March 8, 2019
Postoperative Clinical Monitoring After Morphine Administration: A Retrospective Multicenter Practice SurveyJulien Raft, Kévin Podrez, Cédric Baumann, et al.Current Drug Safety|March 12, 2019
Adverse Drug Reactions of Anti-Epileptic Drugs in Children with Epilepsy: A Cross-Sectional StudySundeep Kaushik, Deepti Chopra, Suvasini Sharma, et al.Current Drug Safety|November 17, 2018
Glecaprevir/Pibrentasvir Induced Cholestatic Jaundice in a HCV Patient with Renal Failure. A Case PresentationBenedetto Caroleo, Maria Cristina Caroleo, Antonio Cimellaro, et al.Current Drug Safety|October 5, 2019
Drug Withdrawal Due to Safety: A Review of the Data Supporting Withdrawal DecisionNuno Sales Craveiro, Bruno Silva Lopes, Lara Tomás, et al.Current Drug Safety|January 20, 2022
A Randomized, Single Centered, Parallel and Open Labelled Interventional Study on Effectiveness of Clinical Pharmacists on Adverse Event Following Immunization (AEFI) in Pediatric PopulationRonit K Arvind, Faizan A Beerwala, Shashikala C Wali, et al.Current Drug Safety|April 29, 2011
Emerging anabolic treatments in osteoporosisLeif Mosekilde, Ove Tørring, Lars RejnmarkCurrent Drug Safety|November 30, 2011
Evaluation of osteoporosis risk associated with chronic use of morphine, fentanyl and tramadol in adult female ratsVivian BoshraCurrent Drug Safety|November 30, 2011
Hypomagnesaemia/hypokalemia associated with the use of esomeprazoleArmando L Negri, Elisa E Del ValleCurrent Drug Safety|December 2, 2011
Limited hypotensive effect of sildenafil in a high-risk population: a preliminary reportM M Ciulla, P Nicolini, C Benfenati, et al.Pageof 98